X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$8 |
FY25 Half Year results
|
27 Feb 2025 4:35PM |
$0.020 |
$0.020 |
fallen by
0%
|
|
X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$8 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:35PM |
$0.020 |
$0.020 |
fallen by
0%
|
|
X2M - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities were $3.4 million, down 55% on the pcp
- Recurring SaaS and maintenance revenue was $0.8 million, flat on pcp
- Gross margin was 47%, up 10 percentage points on the pcp
- Operating expenditure was $3.2 million, down by 31% on the pcp
- 1H25 cash burn from operating activities was $1.8 million
- South Korea segment continued to be profitable delivering positive EBITDA of $0.1 million
- 7 new enterprise and government customers were acquired bringing the total customer base to 80
- Connected devices were 544,910, up 5% on the pcp
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$188 |
Media Release - Half Year Results
|
27 Feb 2025 4:33PM |
$0.690 |
$0.630 |
fallen by
8.70%
|
|
CDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Half year loss after tax of $7.8 million
- Portfolio down 3.6% over the half year
- Top contributors included Netflix and Meta Platforms
- Major detractors were Whitehaven Coal and BHP
- Interim dividend of 3 cents per share declared
- Annualized yield of 8.7% based on the interim dividend
- Ongoing on-market buy-back of shares issued in DRP
- CDM shares trading at an 11% discount to NTA
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Global X S&P 500 Covered Call ETF (UYLD) |
Financials |
$9 |
Global X Updated Est Distribution Announcement - Feb 2025
|
27 Feb 2025 4:32PM |
$12.120 |
$10.850 |
fallen by
10.48%
|
|
Global X Australian Bank Credit ETF (BANK) |
Financials |
$80 |
Global X Updated Est Distribution Announcement - Feb 2025
|
27 Feb 2025 4:32PM |
$10.040 |
$9.940 |
fallen by
1%
|
|
Global X Nasdaq 100 Covered Call ETF (QYLD) |
Financials |
$19 |
Global X Updated Est Distribution Announcement - Feb 2025
|
27 Feb 2025 4:32PM |
$12.390 |
$11.000 |
fallen by
11.22%
|
|
Dusk Group Limited (DSK) ORDINARY FULLY PAID |
Consumer Discretionary |
$48 |
Update - Dividend/Distribution - DSK
|
27 Feb 2025 4:32PM |
$1.275 |
$0.775 |
fallen by
39.22%
|
|
Renu Energy Limited (RNE) ORDINARY FULLY PAID |
Utilities |
$0 |
Proposed issue of securities - RNE
|
27 Feb 2025 4:30PM |
$0.001 |
$0.001 |
fallen by
0%
|
|
Emperor Energy Limited (EMP) ORDINARY FULLY PAID |
Energy |
$19 |
Half Year Accounts
|
27 Feb 2025 4:29PM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$425 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2025 4:27PM |
$0.258 |
$0.210 |
fallen by
18.45%
|
|
Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$188 |
Dividend/Distribution - CDM
|
27 Feb 2025 4:27PM |
$0.690 |
$0.630 |
fallen by
8.70%
|
|
Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$14,946 |
Change in substantial holding for LAU
|
27 Feb 2025 4:26PM |
$34.700 |
$40.630 |
risen by
17.09%
|
|
Lindsay Australia Limited (LAU) ORDINARY FULLY PAID |
Industrials |
$224 |
Change in substantial holding from SOL
|
27 Feb 2025 4:26PM |
$0.635 |
$0.705 |
risen by
11.02%
|
|
Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$21 |
Half Year Report and Accounts
|
27 Feb 2025 4:25PM |
$0.022 |
$0.012 |
fallen by
45.45%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue declined by 21.8% to $4,521,849.
- Gross profit decreased by 18.0% to $3,839,414.
- Loss after income tax improved by 13.3% to $2,051,505.
- Main reasons for revenue decline included Telstra discontinuing its GPA firewall product.
- The company launched new network management technology called 'opHA Message Bus'.
- Recurring revenue represented 96.5% of total revenue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Opyl Limited (OPL) ORDINARY FULLY PAID |
Information Technology |
$5 |
OPL - Appendix 4D & Half Year Results
|
27 Feb 2025 4:24PM |
$0.021 |
$0.020 |
fallen by
4.76%
|
|
OPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Opyl Limited reported a loss of $683,192 for the half-year ending 31 December 2024.
- Revenue decreased by 82.7% to $42,146 compared to the previous year.
- The company has not declared or paid any dividends during the reporting period.
- A joint venture with X Firm Ltd was established to expand TrialKey into new markets.
- Opyl's cash position was $329,547, with additional funding from loans.
- TrialKey achieved 92% predictive accuracy for clinical trial outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
BPH Energy Ltd (BPH) ORDINARY FULLY PAID |
Financials |
$10 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:23PM |
$0.010 |
$0.008 |
fallen by
20%
|
|
BPH - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH reported a profit of $7,068,242 for the half-year ending 31 December 2024.
- Revenues increased by 94.7% to $390,921.
- The company experienced a fair value gain of $7,730,474 from investments.
- Net assets rose by 31.5%, totaling $38,531,092.
- No dividends were proposed for the current or prior period.
- Material uncertainty exists around the carrying value of loans to Advent Energy Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$671 |
Ceasing to be a substantial holder
|
27 Feb 2025 4:22PM |
$1.255 |
$1.150 |
fallen by
8.37%
|
|
NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$34 |
Half-Year Results Presentation
|
27 Feb 2025 4:22PM |
$0.185 |
$0.200 |
risen by
8.11%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTAW Holdings reported a net loss of $42.84 million in 1H25.
- Revenue for 1H25 was $262.5 million, down from $264.3 million in 1H24.
- Gross profit margin declined to 28.9% from 31.2% year-over-year.
- The decline in profitability was attributed to lower sales volume and price discounting.
- The company has implemented a recovery plan focusing on cost reductions and debt management.
- No dividend will be declared for 1H25 due to poor trading performance.
- NTAW Holdings is transitioning away from the Dunlop brand, which did not meet sales expectations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$425 |
Annual Report
|
27 Feb 2025 4:22PM |
$0.258 |
$0.210 |
fallen by
18.45%
|
|
NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$34 |
Half-Year Results Announcement
|
27 Feb 2025 4:22PM |
$0.185 |
$0.200 |
risen by
8.11%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTAW reported a net loss of $42.8 million for 1H25.
- The loss includes a non-cash impairment charge of $39.2 million.
- Revenue decreased to $262.5 million from $264.3 million in 1H24.
- Gross profit margin fell to 28.9% from 31.2% in 1H24.
- Operating costs rose to 25.7% of revenue compared to 24.1% in 1H24.
- Net operating cash flow was negative $9.7 million.
- The company's net debt position increased to $64.2 million.
- Cost-cutting initiatives are being implemented to improve financial performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$160 |
Half Year Report to 31 December 2024
|
27 Feb 2025 4:21PM |
$0.075 |
$1.570 |
risen by
1,993.33%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax reduced to $488,575 from $2,006,202.
- Revenue decreased slightly from $1,476,906 to $1,378,796.
- The company announced a binding agreement to acquire Metal Powder Works Inc.
- The name change to Metal Powder Works Limited was effective February 18, 2025.
- Net cash used in operating activities was $419,443.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$339 |
Appendix 3Y - Change of Director's Interest Notice x6
|
27 Feb 2025 4:19PM |
$1.150 |
$1.075 |
fallen by
6.52%
|
|
NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$34 |
Appendix 4D & Half Year Financial Report
|
27 Feb 2025 4:19PM |
$0.185 |
$0.200 |
risen by
8.11%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for 1H25 was $262.47 million, a decrease of 0.7% from 1H24.
- NTAW reported a loss of $42.68 million compared to a profit of $0.89 million in the prior period.
- A non-cash impairment charge of $39.17 million was recorded against intangible assets.
- Net assets stood at $86.26 million, down from $117.30 million in June 2024.
- The company will cease distribution of Dunlop products effective July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$188 |
Appendix 4D Half Year Report 31 December 2024
|
27 Feb 2025 4:19PM |
$0.690 |
$0.630 |
fallen by
8.70%
|
|
CDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating loss before tax of $11,840,427 for the half-year ended 31 December 2024.
- Operating profit before tax for the previous year was $10,829,240.
- Gross performance of -3.6% compared to a 6.9% increase in the All Ordinaries Accumulation Index.
- Net investments valued at $186,308,227 as of December 2024.
- Net asset value of $288,228,284 as of December 2024.
- Interim dividend of 3.0 cents per share declared, partially franked at 50%, payable on 30 April 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$671 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:16PM |
$1.255 |
$1.150 |
fallen by
8.37%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited is focused on precision medicines for genetic diseases.
- The company has four first-in-class drug candidates in development.
- Positive data from phase 1/2 studies for VP-001 for Retinitis Pigmentosa Type 11.
- Dosing has commenced for PYC-001 addressing Autosomal Dominant Optic Atrophy.
- Pre-clinical studies for PYC-003 targeting Polycystic Kidney Disease have been completed.
- A clinical candidate has been nominated for Phelan-McDermid Syndrome.
- The company reported a loss of $25.87 million for the half-year ending 31 December 2024.
- PYC aims to raise capital to support development through to 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.